Search results
AbbVie's Migraine Treatment Scores Canadian Approval
Benzinga via Yahoo Finance· 1 year agoHealth Canada has approved AbbVie Inc's (NYSE: ABBV) Ubrelvy (ubrogepant) for the acute treatment of migraine, with or without aura, in adults. Ubrelvy...
Olympic gymnast Aly Raisman felt sick from bright lights at competitions. Now she knows migraines...
INSIDER via Yahoo News· 10 months agoAly Raisman at the 2016 Olympics.AP Photo/Charlie Riedel Six-time Olympic medalist Aly Raisman never...
Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric
Investor's Business Daily· 1 year agoBiohaven is following the same strategy with its remaining drug pipeline as it did prior to Pfizer's...
AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises '23 View
Zacks via Yahoo Finance· 9 months agoAbbVie Inc. ABBV reported adjusted earnings of $2.91 per share for second-quarter 2023, beating the...
AbbVie (ABBV) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 months agoImage source: The Motley Fool. AbbVie (NYSE: ABBV) Q4 2023 Earnings Call Feb 02, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
What's Going On AbbVie Stock On Friday?
Benzinga via Yahoo Finance· 7 days agoFriday, AbbVie Inc (NYSE:ABBV) released an interim analysis of an ongoing Phase 3, open-label 156-week extension study evaluating the long-term safety...
AbbVie's (ABBV) Q2 Earnings Beat Estimates, Revenues Lag
Zacks via Yahoo Finance· 2 years agoAbbVie's earnings (ABBV) beat estimates for second-quarter 2022, while sales miss the same. ABBV's...
3 Dividend Stocks That Are No-Brainer Buys Right Now
Motley Fool via Yahoo Finance· 2 months agoThere are well over 5,000 stocks on the market that pay dividends. It would take you years to analyze each one of them in detail. Fortunately, you don't...
AbbVie Crumbles On Mixed Earnings, Slashes 2022 Profit Outlook
Investor's Business Daily· 2 years agoAbbVie stock crumbled Friday after the drugmaker slashed its 2022 earnings outlook after taking an...
FDA Expands AbbVie's (ABBV) Qulipta Label in Chronic Migraine
Zacks via Yahoo Finance· 1 year agoFollowing FDA's label-expansion approval, AbbVie's (ABBV) Qulipta is the first and the only oral...
